P

Perfusion Extracorporeal Technology (Private limited company)

PEx Tech
BE 0784.827.493 Active ●Rue des Haipes 8, 5030 Gembloux

Perfusion Extracorporeal Technology is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0784.827.493. It was founded on 14-04-2022. Its registered office is in Gembloux. Its main activity is: Office administrative, office support and other business support activities. Its annual accounts for 2025 report equity of € 8 736 and a loss of € 6 541. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 18-10-2026.

Company information

Status
Active
Enterprise number
BE 0784.827.493
VAT registered
Yes
Founded
14-04-2022
Latest accounts
2025
Employees
-
Region
Wallonia
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Rue des Haipes 8, 5030 Gembloux
Main activity
Office administrative, office support and other business support activities
NACE activities
82990 Autres activités de service de soutien aux entreprises nca
86940 Activités de soins infirmiers et de maïeutique

Key figures of Perfusion Extracorporeal Technology

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -6 541€ 2 278-35 %€ 3 484-54 %€ 7 514
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 8 736-43 %€ 15 277+18 %€ 12 998+37 %€ 9 514
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 32 779+11 %€ 29 599+19 %€ 24 853+33 %€ 18 750
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -3 940€ 6 973-26 %€ 9 395-32 %€ 13 859
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Gembloux.

CompanyTown
Mediax Solutions 5030 Gembloux
INFODREAM 5030 Gembloux
IBELCOM 5030 Gembloux
BOULANGERIE DUCHENE - COULON 5030 Gembloux
SAMOLA 5030 Gembloux
ZHAOffice 5030 Gembloux
ENAGRI 5030 Gembloux
IMMO PROTECT 5030 Gembloux
Looking for more information about Perfusion Extracorporeal Technology?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Perfusion Extracorporeal Technology still active? Yes. The Crossroads Bank for Enterprises lists Perfusion Extracorporeal Technology as active.

What is the VAT number of Perfusion Extracorporeal Technology? The VAT number of Perfusion Extracorporeal Technology is BE 0784.827.493.

When was Perfusion Extracorporeal Technology founded? Perfusion Extracorporeal Technology was founded on 14-04-2022.

What is the address of Perfusion Extracorporeal Technology? The current registered office of Perfusion Extracorporeal Technology is Rue des Haipes 8, 5030 Gembloux.

When did Perfusion Extracorporeal Technology last file annual accounts? The latest annual accounts of Perfusion Extracorporeal Technology were filed on 11-06-2026.

Does Perfusion Extracorporeal Technology file its annual accounts on time? Yes. Perfusion Extracorporeal Technology filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is Perfusion Extracorporeal Technology financially healthy? Addrly gives Perfusion Extracorporeal Technology a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Perfusion Extracorporeal Technology profitable? The annual accounts of Perfusion Extracorporeal Technology for 2025 show a loss of € 6 541.

What is the equity of Perfusion Extracorporeal Technology? The equity of Perfusion Extracorporeal Technology was € 8 736 at the close of the 2025 financial year.

Who are the directors of Perfusion Extracorporeal Technology? The annual accounts of Perfusion Extracorporeal Technology record 1 mandate. The name, role and dates are visible with a free account.

Can Perfusion Extracorporeal Technology receive Peppol e-invoices? Yes. Perfusion Extracorporeal Technology is registered on the Peppol network and can receive structured electronic invoices.

What does Perfusion Extracorporeal Technology do? The main activity of Perfusion Extracorporeal Technology is: Office administrative, office support and other business support activities.

Sources

How Addrly builds and refreshes this data